US to buy 200 million more doses of Moderna's coronavirus shot

This is in anticipation that its citizens may require booster shots, media reports said.

moderna
IANS Washington
2 min read Last Updated : Jun 17 2021 | 5:54 PM IST

The US will buy an additional 200 million doses of Moderna's Covid vaccine in anticipation that its citizens may require booster shots, media reports said.

The vaccine doses' delivery is expected to begin this fall and continue till next year and will help the Biden administration to inoculate children under 12, once the US Food and Drug Administration approves, the New York Times reported on Wednesday, citing officials familiar with the plan.

The new doses bring the total amount of Moderna vaccine ordered by the US government to 500 million doses, of which 217 million doses had already been delivered as of June 14, the company said in a statement on Wednesday.

Of the new doses, Moderna expects to deliver 110 million in the fourth quarter of this year, and 90 million in the first quarter of 2022, it said.

"We appreciate the collaboration with the US government for these additional doses of the Moderna Covid-19 vaccine, which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic," Moderna CEO Stephane Bancel, said in a statement.

"We remain focused on being proactive as the virus evolves by leveraging the flexibility of our mRNA platform to stay ahead of emerging variants," he said.

Under its existing contract with Moderna, the federal government had until Tuesday to exercise the option to purchase doses for future vaccination needs at the same price it is currently paying -- about $16.50 a dose.

Similar conversations are underway with Pfizer-BioNTech, which also makes a two-dose mRNA vaccine, but no agreement has been reached, one of the officials was quoted as saying to the NYT.

--IANS

rvt/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusUnited StatesCoronavirus Vaccine

First Published: Jun 17 2021 | 5:54 PM IST

Next Story